SENESTECH INC (SNES) Stock Price & Overview

NASDAQ:SNESUS81720R6045

Current stock price

1.78 USD
+0.04 (+2.3%)
Last:

The current stock price of SNES is 1.78 USD. Today SNES is up by 2.3%. In the past month the price decreased by -24.89%. In the past year, price decreased by -17.97%.

SNES Key Statistics

52-Week Range1.3 - 6.24
Current SNES stock price positioned within its 52-week range.
1-Month Range1.7 - 2.4
Current SNES stock price positioned within its 1-month range.
Market Cap
9.434M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-9.97
Dividend Yield
N/A

SNES Stock Performance

Today
+2.3%
1 Week
-7.29%
1 Month
-24.89%
3 Months
-23.61%
Longer-term
6 Months -63.37%
1 Year -17.97%
2 Years -73.92%
3 Years -99.00%
5 Years -99.96%
10 Years N/A

SNES Stock Chart

SENESTECH INC / SNES Daily stock chart

SNES Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to SNES. When comparing the yearly performance of all stocks, SNES is a bad performer in the overall market: 83.18% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

SNES Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to SNES. SNES scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

SNES Earnings

On March 12, 2026 SNES reported an EPS of -0.35 and a revenue of 421.00K. The company missed EPS expectations (-14.38% surprise) and missed revenue expectations (-46.81% surprise).

Next Earnings DateMay 6, 2026
Last Earnings DateMar 12, 2026
PeriodQ4 / 2025
EPS Reported-$0.35
Revenue Reported421K
EPS Surprise -14.38%
Revenue Surprise -46.81%

SNES Forecast & Estimates

7 analysts have analysed SNES and the average price target is 10.2 USD. This implies a price increase of 473.03% is expected in the next year compared to the current price of 1.78.

For the next year, analysts expect an EPS growth of 72.07% and a revenue growth 24.9% for SNES


Analysts
Analysts82.86
Price Target10.2 (473.03%)
EPS Next Y72.07%
Revenue Next Year24.9%

SNES Groups

Sector & Classification

Sub-Industry
Pharmaceuticals
Index Membership

SNES Financial Highlights

Over the last trailing twelve months SNES reported a non-GAAP Earnings per Share(EPS) of -9.97. The EPS increased by 96.76% compared to the year before.


Income Statements
Revenue(TTM)1.86M
Net Income(TTM)-5.83M
Industry RankSector Rank
PM (TTM) N/A
ROA -39.89%
ROE -51.41%
Debt/Equity 0.01
Chartmill High Growth Momentum
EPS Q2Q%71.31%
Sales Q2Q%-15.97%
EPS 1Y (TTM)96.76%
Revenue 1Y (TTM)55.66%

SNES Ownership

Ownership
Inst Owners26.79%
Shares5.30M
Float5.00M
Ins OwnersN/A
Short Float %0.99%
Short Ratio0.88

About SNES

Company Profile

SNES logo image SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Surprise, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.

Company Info

IPO: 2016-12-08

SENESTECH INC

13430 North Dysart Road,, Suite 105

Surprise ARIZONA 85027 US

CEO: Kenneth Siegel

Employees: 23

SNES Company Website

SNES Investor Relations

Phone: 19287794143

SENESTECH INC / SNES FAQ

What does SNES do?

SenesTech, Inc. engages in the development and commercialization of proprietary technology for the management of animal pest populations. The company is headquartered in Surprise, Arizona and currently employs 23 full-time employees. The company went IPO on 2016-12-08. The Company’s product lines of fertility control products are: ContraPest, Evolve Rat, and Evolve Mouse. Its product, ContraPest, is a liquid bait containing the active ingredients 4-vinylcyclohexene diepoxide (VCD) and triptolide. ContraPest targets the reproductive systems of both male and female Norway and roof rats beginning with the first breeding cycle following consumption, which can lead to sustained reductions in the rat population. The Evolve Rat is a soft bait product that contains the active ingredient, cottonseed oil, which reduces fertility in both male and female rats. The Evolve Mouse, a modified version of soft bait technology containing the active ingredient cottonseed oil, which limits reproduction of male and female mice after one to two breeding cycles following consumption.


What is the stock price of SENESTECH INC today?

The current stock price of SNES is 1.78 USD. The price increased by 2.3% in the last trading session.


What is the dividend status of SENESTECH INC?

SNES does not pay a dividend.


How is the ChartMill rating for SENESTECH INC?

SNES has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Which stock exchange lists SNES stock?

SNES stock is listed on the Nasdaq exchange.


Is SENESTECH INC (SNES) stock a good buy?

This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on SNES.


Can you provide the short interest for SNES stock?

The outstanding short interest for SENESTECH INC (SNES) is 0.99% of its float.